To view the PDF file, sign up for a MySharenet subscription.

DIS-CHEM PHARMACIES LIMITED - Dealings in securities

Release Date: 26/11/2021 10:00
Code(s): DCP     PDF:  
Wrap Text
Dealings in securities

Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE share code: DCP
ISIN: ZAE000227831
(“Dis-Chem” or the “Company”)

DEALINGS IN DIS-CHEM SHARES BY AN ASSOCIATE OF A PRESCRIBED OFFICER OF THE COMPANY

Shareholders of Dis-Chem are advised of the following dealings in the Company’s securities.

In compliance with sections 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the following
information is disclosed:



Name of prescribed officer:             Mr Brian Epstein

Name of associate:                      Busdis Proprietary Limited, a company owned by the prescribed

                                        officer’s family trust

Nature and extent of interest:          Indirect beneficial

Class of securities:                    Ordinary shares

Number of shares:                       1 550 100

Price per security:                     R34.0105

Total value of transaction:             R52 719 676

Date of transaction:                    24 November 2021



Class of securities:                    Ordinary shares

Number of shares:                       214 900

Price per security:                     R34.00

Total value of transaction:             R7 306 600

Date of transaction:                    25 November 2021

Nature of transactions:                 On-market disposal of Dis-Chem ordinary shares



Clearance for the above transactions were obtained in accordance with Dis-Chem’s trading policy.

By order of the Board
Nikki Lumley
Company Secretary

26 November 2021


Sponsor
The Standard Bank of South Africa Limited

Date: 26-11-2021 10:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story